Letter: Association of targeted intense pulse light system UVA1-UVB and fluticasone in the treatment of vitiligo: Prospective study of 10 patients.
Vitiligo is an acquired pigmentary disorder treated frequently with PUVA and narrowband UVB phototherapy. These total body treatments are associated with side-effects in the lesional or nonlesional skin. A prospective study using a novel multiwavelength targeted Intense Pulse Light System UVA1-UVB in association with fluticasone cream was undertaken. Of the ten patients who participated in the study, only eight completed it. Four patients had grade 1 improvement (1-25%); one had grade 3 (51-75%); two had worsening of the lesions after sun exposure; one had no skin repigmentation.
Joana Dias
JD
Coelho
Ana
A
Ferreira
D000328:Adult; D000368:Aged; D000730:Androstadienes / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D000068298:Fluticasone; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods*; D014820:Vitiligo / Q000532:radiotherapy*
D000730:Androstadienes; D003879:Dermatologic Agents; D000068298:Fluticasone